MediciNova Inc MNOV

US Biotechnology

$1.92 ▼ -8.57% ($-0.18)

Open $2.05

Prev Close $2.10

Day Range $1.77 – $2.07

52W Range $1.17 – $3.90

Market Cap $94.50M

Beta 0.67

EPS (TTM) $-0.22

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2006-12-01
Shares Out.	49,220,000
Website	medicinova.com/ ↗
Phone	18583731500
Employees	6
Revenue	$458,439
Gross Profit	$458,439
Net Income	-$2.3M
Free Cash Flow	-$9.1M
Total Assets	$40.4M
Total Liabilities	$3.2M
Equity	$37.3M

About MediciNova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

MediciNova Inc is a publicly traded company under the ticker symbol MNOV on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.